jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Young PharmacistsNOW IN
Article

Cost-effectiveness of Hydrocortisone Injection, Symbicort Inhaler and Prednisolone Tablets Used in Treatment of Asthma in Alshaab Teaching Hospital Khartoum, Sudan

Mansir Abdulrahman1, Mousnad Mohamed Awad1★, Asma Noureldaim Mohamed Ahmad1, Ahmed El Sayed2★ Corresponding author

  1. 1Department of Pharmacy Practice, Faculty of Pharmacy, International University of Africa, Khartoum, SUDAN.
  2. 2Department of Surgery, Alzaeim Alazhari University, Khartoum North, SUDAN.

CORRESPONDENCE

Mousnad Mohamed Awad

Department of Pharmacy Practice, Faculty of Pharmacy, International University of Africa, Khartoum, SUDAN.

mousnad@gmail.com

Received: 24-10-2022; Revised: 30-01-2023; Accepted: 11-02-2023.

Volume 15, Issue 2 · pp. 360–367 · PUBLISHED · DOI: 10.5530/jyp.2023.15.48

View on JYP original site ↗

ABSTRACT

Background:Asthma is a chronic disease and one of the most familiar long-term respiratory diseases affecting millions of adults worldwide. High utilisation of healthcare resources in treating asthma and limited resources allocated to the disease has imposed the use of Pharmaco-economics evaluation methods such as cost-effectiveness analysis in healthcare decision-making. Hence, the present study is planned to evaluate the cost-effectiveness of corticosteroid preparations used in treating asthmatic patients at Alshaab Teaching Hospital (ASH) Khartoum, Khartoum State, Sudan. Materials and Methods: A hospital-based cross-sectional design, whereby the cost and outcome of corticosteroid preparations were collected together. One hundred and thirty-nine adult asthmatic patients were systematically selected as the sample size. The data were collected using EQ-5D-3L Arabic version questionnaire and data collection forms and analysed using Statistical Package for Social Sciences (IBM) version 24.0. Results:In this study, out of 139 patients, the majority of them (58%) were females, fell within the 16-40 age group category (38%) and were married (82%). Our findings showed that the Symbicort inhaler was the most expensive preparation with an Average Cost-Effectiveness Ratio (ACER) of 3,283.10 SDG ($4901) per treatment. Prednisolone tablet was the least expensive, with an ACER of 643.40 SDG ($ 96) per treatment, the most reasonable alternative concerning effectiveness, and the most efficient preparation concerning effectiveness-adjusted costs. Conclusion: This study concluded that the prevalence of asthma and utilisation of pharmaceutical products and services among adult asthmatic patients in ASH was higher in females (58%) and those in the 16-40 age group. The Symbicort inhaler was the most expensive preparation, and the Prednisolone tablet was the least expensive and most cost-effective of the three preparations evaluated in ASH.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Abdulrahman, M., Awad, M. M., Ahmad, A. N. M., & Sayed, A. E. (). Cost-effectiveness of Hydrocortisone Injection, Symbicort Inhaler and Prednisolone Tablets Used in Treatment of Asthma in Alshaab Teaching Hospital Khartoum, Sudan. Journal of Young Pharmacists, 15(2), 360–367. https://doi.org/10.5530/jyp.2023.15.48